Antifungal activity of redox-active benzaldehydes that target cellular antioxidation

Annals of Clinical Microbiology and Antimicrobials

Volumn 10, Issue , 2011, Pages

  Kim, Jong H ^a   Chan, Kathleen L ^a   Mahoney, Noreen ^a   Campbell, Bruce C ^a  

^a WESTERN REGIONAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXY 3 METHOXY BENZALDEHYDE; 2 HYDROXY 5 METHOXY BENZALDEHYDE; 2 METHOXYBENZALDEHYDE; 2,3 DIMETHOXYBENZALDEHYDE; 2,5 DIMETHOXYBENZALDEHYDE; 3,5 DIMETHOXYBENZALDEHYDE; ANTIFUNGAL AGENT; BENZALDEHYDE DERIVATIVE; CINNAMALDEHYDE; FLUDIOXONIL; FUNGICIDE; PYRROLE DERIVATIVE; UNCLASSIFIED DRUG; ANTIOXIDANT; FUNGAL PROTEIN; SUPEROXIDE DISMUTASE;

ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS TERREUS; CHEMOSENSITIZATION; CONTROLLED STUDY; DELETION MUTANT; DRUG EFFICACY; FUNGAL STRAIN; FUNGUS GROWTH; GENE TARGETING; GROWTH INHIBITION; INVASIVE ASPERGILLOSIS; MINIMUM INHIBITORY CONCENTRATION; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATIVE STRESS; PENICILLIUM EXPANSUM; SACCHAROMYCES CEREVISIAE; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; CHEMISTRY; DRUG EFFECT; FUNGUS; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MYCOSIS; OXIDATION REDUCTION REACTION;

ANTIFUNGAL AGENTS; ANTIOXIDANTS; BENZALDEHYDES; FUNGAL PROTEINS; FUNGI; HUMANS; MYCOSES; OXIDATION-REDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; SUPEROXIDE DISMUTASE;

EID: 79957639708     PISSN: None     EISSN: 14760711     Source Type: Journal    
DOI: 10.1186/1476-0711-10-23     Document Type: Article

References (78)

1. Ostrosky-Zeichner L, Casadevall A, Galgiani JN, Odds FC, Rex JH. An insight into the antifungal pipeline: selected new molecules and beyond. Nat Rev Drug Discov 2010, 9:719-727. 10.1038/nrd3074, 20725094.
2. Takimoto H, Machida K, Ueki M, Tanaka T, Taniguchi M. UK-2A, B, C and D, novel antifungal antibiotics from Streptomyces sp. 517-02. IV. Comparative studies of UK-2A with antimycin A3 on cytotoxic activity and reactive oxygen species generation in LLC-PK1 cells. J Antibiot (Tokyo) 1999, 52:480-484.
3. Di Santo R. Natural products as antifungal agents against clinically relevant pathogens. Nat Prod Rep 2010, 27:1084-1098. 10.1039/b914961a, 20485730.
4. Moore CB, Sayers N, Mosquera J, Slaven J, Denning DW. Antifungal drug resistance in Aspergillus. J Infect 2000, 41:203-220. 10.1053/jinf.2000.0747, 11120607.
5. Charlier C, Hart E, Lefort A, Ribaud P, Dromer F, Denning DW, Lortholary O. Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?. J Antimicrob Chemother 2006, 57:384-410. 10.1093/jac/dki473, 16449304.
6. Spanakis EK, Aperis G, Mylonakis E. New agents for the treatment of fungal infections: clinical efficacy and gaps in coverage. Clin Infect Dis 2006, 43:1060-1068. 10.1086/507891, 16983621.
7. Holmes AR, Lin YH, Niimi K, Lamping E, Keniya M, Niimi M, Tanabe K, Monk BC, Cannon RD. ABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates. Antimicrob Agents Chemother 2008, 52:3851-3862. 10.1128/AAC.00463-08, 2573144, 18710914.
8. Barrett D. From natural products to clinically useful antifungals. Biochim Biophys Acta 2002, 1587:224-233.
9. Jacob MR, Walker LA. Natural products and antifungal drug discovery. Methods Mol Med 2005, 118:83-109.
10. Tawata S, Taira S, Kobamoto N, Zhu J, Ishihara M, Toyama S. Synthesis and antifungal activity of cinnamic acid esters. Biosci Biotechnol Biochem 1996, 60:909-910. 10.1271/bbb.60.909, 8704323.
11. Florianowicz T. Penicillium expansum growth and production of patulin in the presence of benzoic acid and its derivatives. Acta Microbiol Pol 1998, 47:45-53.
12. Agarwal M, Walia S, Dhingra S, Khambay BP. Insect growth inhibition, antifeedant and antifungal activity of compounds isolated/derived from Zingiber officinale Roscoe (ginger) rhizomes. Pest Manag Sci 2001, 57:289-300. 10.1002/ps.263, 11455660.
13. Guillen F, Evans CS. Anisaldehyde and veratraldehyde acting as redox cycling agents for H2O2 production by Pleurotus eryngii. Appl Environ Microbiol 1994, 60:2811-2817. 201727, 16349349.
14. Jacob C. A scent of therapy: pharmacological implications of natural products containing redox-active sulfur atoms. Natural Product Reports 2006, 23:851-863. 10.1039/b609523m, 17119635.
15. Holdom MD, Hay RJ, Hamilton AJ. The Cu,Zn superoxide dismutases of Aspergillus flavus, Aspergillus niger, Aspergillus nidulans, and Aspergillus terreus: purification and biochemical comparison with the Aspergillus fumigatus Cu,Zn superoxide dismutase. Infect Immun 1996, 64:3326-3332. 174225, 8757871.
16. Hamilton AJ, Holdom MD. Antioxidant systems in the pathogenic fungi of man and their role in virulence. Med Mycol 1999, 37:375-389. 10.1046/j.1365-280X.1999.00208.x, 10647118.
17. Washburn RG, Gallin JI, Bennett JE. Oxidative killing of Aspergillus fumigatus proceeds by parallel myeloperoxidase-dependent and -independent pathways. Infect Immun 1987, 55:2088-2092. 260661, 3040589.
18. Lee J, Kwon ES, Kim DW, Cha J, Roe JH. Regulation and the role of Cu,Zn-containing superoxide dismutase in cell cycle progression of Schizosaccharomyces pombe. Biochem Biophys Res Commun 2002, 297:854-862. 10.1016/S0006-291X(02)02290-8, 12359231.
19. Harris N, Costa V, MacLean M, Mollapour M, Moradas-Ferreira P, Piper PW. MnSOD overexpression extends the yeast chronological (G0) life span but acts independently of Sir2p histone deacetylase to shorten the replicative life span of dividing cells. Free Radic Biol Med 2003, 34:1599-1606. 10.1016/S0891-5849(03)00210-7, 12788479.
20. Michalkova-Papajova D, Obernauerova M, Subik J. Role of the PDR gene network in yeast susceptibility to the antifungal antibiotic mucidin. Antimicrob Agents Chemother 2000, 44:418-420. 10.1128/AAC.44.2.418-420.2000, 89695, 10639374.
21. Fujita K, Tani K, Usuki Y, Tanaka T, Taniguchi M. Growth inhibition dependent on reactive oxygen species generated by C9-UK-2A, a derivative of the antifungal antibiotic UK-2A, in Saccharomyces cerevisiae. J Antibiot (Tokyo) 2004, 57:511-517.
22. Ruy F, Vercesi AE, Kowaltowski AJ. Inhibition of specific electron transport pathways leads to oxidative stress and decreased Candida albicans proliferation. J Bioenerg Biomembr 2006, 38:129-135. 10.1007/s10863-006-9012-7, 17053999.
23. Longo VD, Gralla EB, Valentine JS. Superoxide dismutase activity is essential for stationary phase survival in Saccharomyces cerevisiae. Mitochondrial production of toxic oxygen species in vivo. J Biol Chem 1996, 271:12275-12280. 10.1074/jbc.271.21.12275, 8647826.
24. Grant CM. Role of the glutathione/glutaredoxin and thioredoxin systems in yeast growth and response to stress conditions. Mol Microbiol 2001, 39:533-541. 10.1046/j.1365-2958.2001.02283.x, 11169096.
25. Goswami M, Mangoli SH, Jawali N. Involvement of reactive oxygen species in the action of ciprofloxacin against Escherichia coli. Antimicrob Agents Chemother 2006, 50:949-954. 10.1128/AAC.50.3.949-954.2006, 1426460, 16495256.
26. Graybill JR, Burgess DS, Hardin TC. Key issues concerning fungistatic versus fungicidal drugs. Eur J Clin Microbiol Infect Dis 1997, 16:42-50. 10.1007/BF01575120, 9063673.
27. Sokol-Anderson ML, Brajtburg J, Medoff G. Amphotericin B-induced oxidative damage and killing of Candida albicans. J Infect Dis 1986, 154:76-83. 10.1093/infdis/154.1.76, 3519792.
28. Okamoto Y, Aoki S, Mataga I. Enhancement of amphotericin B activity against Candida albicans by superoxide radical. Mycopathologia 2004, 158:9-15.
29. Niimi K, Harding DR, Parshot R, King A, Lun DJ, Decottignies A, Niimi M, Lin S, Cannon RD, Goffeau A, Monk BC. Chemosensitization of fluconazole resistance in Saccharomyces cerevisiae and pathogenic fungi by a D-octapeptide derivative. Antimicrob Agents Chemother 2004, 48:1256-1271. 10.1128/AAC.48.4.1256-1271.2004, 375246, 15047528.
30. Lavigne JP, Brunel JM, Chevalier J, Pages JM. Squalamine, an original chemosensitizer to combat antibiotic-resistant gram-negative bacteria. J Antimicrob Chemother 2010, 65:799-801. 10.1093/jac/dkq031, 20147322.
31. Denning DW. Invasive aspergillosis. Clin Infect Dis 1998, 26:781-803. 10.1086/513943, 9564455.
32. Leslie JF, Bandyopadhyay R, Visconti A. Mycotoxins: Detection Methods, Management, Public Health and Agricultural Trade 2008, Oxfordshire, U.K.: CAB International.
33. Fliege R, Metzler M. The mycotoxin patulin induces intra- and intermolecular protein crosslinks in vitro involving cysteine, lysine, and histidine side chains, and alpha-amino groups. Chem Biol Interact 1999, 123:85-103. 10.1016/S0009-2797(99)00123-4, 10597903.
34. Mahfoud R, Maresca M, Garmy N, Fantini J. The mycotoxin patulin alters the barrier function of the intestinal epithelium: mechanism of action of the toxin and protective effects of glutathione. Toxicol Appl Pharmacol 2002, 181:209-218. 10.1006/taap.2002.9417, 12079430.
35. Arafat W, Kern D, Dirheimer G. Inhibition of aminoacyl-tRNA synthetases by the mycotoxin patulin. Chem Biol Interact 1985, 56:333-349. 10.1016/0009-2797(85)90015-8, 3907866.
36. Arafat W, Musa MN. Patulin-induced inhibition of protein synthesis in hepatoma tissue culture. Res Commun Mol Pathol Pharmacol 1995, 87:177-186.
37. McCallum JL, Tsao R, Zhou T. Factors affecting patulin production by Penicillium expansum. J Food Prot 2002, 65:1937-1942.
38. Sabater-Vilar M, Maas RF, De Bosschere H, Ducatelle R, Fink-Gremmels J. Patulin produced by an Aspergillus clavatus isolated from feed containing malting residues associated with a lethal neurotoxicosis in cattle. Mycopathologia 2004, 158:419-426. 10.1007/s11046-005-2877-x, 15702266.
39. Saccharomyces Genome Database. , http://www.yeastgenome.org
40. Parsons AB, Brost RL, Ding H, Li Z, Zhang C, Sheikh B, Brown GW, Kane PM, Hughes TR, Boone C. Integration of chemical-genetic and genetic interaction data links bioactive compounds to cellular target pathways. Nat Biotechnol 2004, 22:62-69. 10.1038/nbt919, 14661025.
41. Tonukari NJ, Scott-Craig JS, Walton JD. The Cochliobolus carbonum SNF1 gene is required for cell wall-degrading enzyme expression and virulence on maize. Plant Cell 2000, 12:237-248. 139761, 10662860.
42. Kim JH, Campbell BC, Yu J, Mahoney N, Chan KL, Molyneux RJ, Bhatnagar D, Cleveland TE. Examination of fungal stress response genes using Saccharomyces cerevisiae as a model system: targeting genes affecting aflatoxin biosynthesis by Aspergillus flavus Link. Appl Microbiol Biotechnol 2005, 67:807-815. 10.1007/s00253-004-1821-1, 15614562.
43. Xue T, Nguyen CK, Romans A, May GS. A mitogen-activated protein kinase that senses nitrogen regulates conidial germination and growth in Aspergillus fumigatus. Eukaryotic Cell 2004, 3:557-560. 10.1128/EC.3.2.557-560.2004, 387654, 15075285.
44. Reyes G, Romans A, Nguyen CK, May GS. Novel mitogen-activated protein kinase MpkC of Aspergillus fumigatus is required for utilization of polyalcohol sugars. Eukaryotic Cell 2006, 5:1934-1940. 10.1128/EC.00178-06, 1694801, 16998074.
45. Vincent JM. Distortion of fungal hyphae in the presence of certain inhibitors. Nature 1947, 159:850.
46. Kim JH, Campbell B, Mahoney N, Chan K, Molyneux R, May G. Chemosensitization prevents tolerance of Aspergillus fumigatus to antimycotic drugs. Biochem Biophys Res Commun 2008, 372:266-271. 10.1016/j.bbrc.2008.05.030, 18486603.
47. Isenberg HD. Clinical Microbiology Procedures Handbook 1992, Washington, D. C.: American Society for Microbiology, 1.
48. Clinical and Laboratory Standards Institute (CLSI) Reference method for broth dilution antifungal susceptibility testing of filamentous fungi: Approved standard-Second edition. CLSI document M38-A2 2008, Wayne, PA: Clinical and Laboratory Standards Institute, Clinical and Laboratory Standards Institute (CLSI).
49. Meletiadis J, Antachopoulos C, Stergiopoulou T, Pournaras S, Roilides E, Walsh TJ. Differential fungicidal activities of amphotericin B and voriconazole against Aspergillus species determined by microbroth methodology. Antimicrob Agents Chemother 2007, 51:3329-3337. 10.1128/AAC.00345-07, 2043246, 17576838.
50. Ingels FM, Augustijns PF. Biological, pharmaceutical, and analytical considerations with respect to the transport media used in the absorption screening system, Caco-2. J Pharm Sci 2003, 92:1545-1558. 10.1002/jps.10408, 12884242.
51. Kim JH, Campbell BC, Mahoney N, Chan KL, Molyneux RJ. Chemosensitization of aflatoxigenic fungi to antimycin A and strobilurin using salicylaldehyde, a volatile natural compound targeting cellular antioxidation system. Mycopathologia 2011, 171:291-298. 10.1007/s11046-010-9356-8, 20803256.
52. Senter PD, Al-Abed Y, Metz CN, Benigni F, Mitchell RA, Chesney J, Han J, Gartner CG, Nelson SD, Todaro GJ, Bucala R. Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolites. Proc Natl Acad Sci USA 2002, 99:144-149. 10.1073/pnas.011569399, 117529, 11773615.
53. Rep M, Krantz M, Thevelein JM, Hohmann S. The transcriptional response of Saccharomyces cerevisiae to osmotic shock. Hot1p and Msn2p/Msn4p are required for the induction of subsets of high osmolarity glycerol pathway-dependent genes. J Biol Chem 2000, 275:8290-8300. 10.1074/jbc.275.12.8290, 10722658.
54. Maridonneau I, Braquet P, Garay RP. Na+ and K+ transport damage induced by oxygen free radicals in human red cell membranes. J Biol Chem 1983, 258:3107-3113.
55. Kojima K, Takano Y, Yoshimi A, Tanaka C, Kikuchi T, Okuno T. Fungicide activity through activation of a fungal signalling pathway. Mol Microbiol 2004, 53:1785-1796. 10.1111/j.1365-2958.2004.04244.x, 15341655.
56. Rep M, Proft M, Remize F, Tamas M, Serrano R, Thevelein JM, Hohmann S. The Saccharomyces cerevisiae Sko1p transcription factor mediates HOG pathway-dependent osmotic regulation of a set of genes encoding enzymes implicated in protection from oxidative damage. Mol Microbiol 2001, 40:1067-1083. 10.1046/j.1365-2958.2001.02384.x, 11401713.
57. Yamazaki T, Inagaki Y, Fujii T, Ohwada J, Tsukazaki M, Umeda I, Kobayashi K, Shimma N, Page MG, Arisawa M. In vitro activity of isavuconazole against 140 reference fungal strains and 165 clinically isolated yeasts from Japan. Int J Antimicrob Agents 2010, 36:324-331. 10.1016/j.ijantimicag.2010.06.003, 20674282.
58. McCusker JH, Clemons KV, Stevens DA, Davis RW. Genetic characterization of pathogenic Saccharomyces cerevisiae isolates. Genetics 1994, 136:1261-1269. 1205906, 8013903.
59. Elskens MT, Penninckx MJ. Thiram and dimethyldithiocarbamic acid interconversion in Saccharomyces cerevisiae: a possible metabolic pathway under the control of the glutathione redox cycle. Appl Environ Microbiol 1997, 63:2857-2862. 168582, 9212433.
60. Schwartz MA, Madhani HD. Principles of MAP kinase signaling specificity in Saccharomyces cerevisiae. Annu Rev Genet 2004, 38:725-748. 10.1146/annurev.genet.39.073003.112634, 15568991.
61. Levin DE. Cell wall integrity signaling in Saccharomyces cerevisiae. Microbiol Mol Biol Rev 2005, 69:262-291. 10.1128/MMBR.69.2.262-291.2005, 1197416, 15944456.
62. Motoyama T, Kadokura K, Ohira T, Ichiishi A, Fujimura M, Yamaguchi I, Kudo T. A two-component histidine kinase of the rice blast fungus is involved in osmotic stress response and fungicide action. Fungal Genet Biol 2005, 42:200-212. 10.1016/j.fgb.2004.11.002, 15707841.
63. Hagiwara D, Matsubayashi Y, Marui J, Furukawa K, Yamashino T, Kanamaru K, Kato M, Abe K, Kobayashi T, Mizuno T. Characterization of the NikA histidine kinase implicated in the phosphorelay signal transduction of Aspergillus nidulans, with special reference to fungicide responses. Biosci Biotechnol Biochem 2007, 71:844-847. 10.1271/bbb.70051, 17341812.
64. Ochiai N, Fujimura M, Motoyama T, Ichiishi A, Usami R, Horikoshi K, Yamaguchi I. Characterization of mutations in the two-component histidine kinase gene that confer fludioxonil resistance and osmotic sensitivity in the os-1 mutants of Neurospora crassa. Pest Manag Sci 2001, 57:437-442. 10.1002/ps.302, 11374161.
65. Kanetis L, Forster H, Jones CA, Borkovich KA, Adaskaveg JE. Characterization of genetic and biochemical mechanisms of fludioxonil and pyrimethanil resistance in field isolates of Penicillium digitatum. Phytopathology 2008, 98:205-214. 10.1094/PHYTO-98-2-0205, 18943197.
66. Boisnard S, Ruprich-Robert G, Florent M, Da Silva B, Chapeland-Leclerc F, Papon N. Role of Sho1p adaptor in the pseudohyphal development, drugs sensitivity, osmotolerance and oxidant stress adaptation in the opportunistic yeast Candida lusitaniae. Yeast 2008, 25:849-859. 10.1002/yea.1636, 19061190.
67. Cowen LE, Lindquist S. Hsp90 potentiates the rapid evolution of new traits: drug resistance in diverse fungi. Science 2005, 309:2185-2189. 10.1126/science.1118370, 16195452.
68. Cowen LE, Carpenter AE, Matangkasombut O, Fink GR, Lindquist S. Genetic architecture of Hsp90-dependent drug resistance. Eukaryot Cell 2006, 5:2184-2188. 10.1128/EC.00274-06, 1694807, 17056742.
69. Young JC, Moarefi I, Hartl FU. Hsp90: a specialized but essential protein-folding tool. J Cell Biol 2001, 154:267-273. 10.1083/jcb.200104079, 2150759, 11470816.
70. Picard D. Heat-shock protein 90, a chaperone for folding and regulation. Cell Mol Life Sci 2002, 59:1640-1648. 10.1007/PL00012491, 12475174.
71. Pratt WB, Toft DO. Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery. Exp Biol Med (Maywood) 2003, 228:111-133.
72. Sangster TA, Lindquist S, Queitsch C. Under cover: causes, effects and implications of Hsp90-mediated genetic capacitance. Bioessays 2004, 26:348-362. 10.1002/bies.20020, 15057933.
73. Byun HO, Kim HY, Lim JJ, Seo YH, Yoon G. Mitochondrial dysfunction by complex II inhibition delays overall cell cycle progression via reactive oxygen species production. J Cell Biochem 2008, 104:1747-1759. 10.1002/jcb.21741, 18395845.
74. Fostel JM, Lartey PA. Emerging novel antifungal agents. Drug Discov Today 2000, 5:25-32. 10.1016/S1359-6446(99)01430-0, 10637546.
75. Chamilos G, Lewis RE, Kontoyiannis DP. Inhibition of Candida parapsilosis mitochondrial respiratory pathways enhances susceptibility to caspofungin. Antimicrob Agents Chemother 2006, 50:744-747. 10.1128/AAC.50.2.744-747.2006, 1366909, 16436735.
76. Yan L, Li M, Cao Y, Gao P, Cao Y, Wang Y, Jiang Y. The alternative oxidase of Candida albicans causes reduced fluconazole susceptibility. J Antimicrob Chemother 2009, 64:764-773. 10.1093/jac/dkp273, 19656781.
77. Faria NCG, Kim JH, Gonçalves LAP, Martins M, Chan KL, Campbell BC. Enhanced activity of antifungal drugs using natural phenolics against yeast strains of Candida and Cryptococcus. Lett Appl Microbiol 2011, 52:506-513. 10.1111/j.1472-765X.2011.03032.x, 21332761.
78. McIntosh L. Molecular biology of the alternative oxidase. Plant Physiol 1994, 105:781-786. 10.1104/pp.105.3.781, 160724, 8058835.